Ray Liu

Antitumor Activity of the Investigational Proteasome Inhibitor MLN9708 in Mouse Models of B-cell and Plasma Cell Malignancies

Edmund C. Lee, Michael Fitzgerald, Bret Bannerman et al. · Clinical Cancer Research · 2011 · 106 citations

Medicine, Oncology, Pharmacology +16

Novel DNA Damage Checkpoints Mediating Cell Death Induced by the NEDD8-Activating Enzyme Inhibitor MLN4924

Jonathan L. Blank, Xiaozhen J. Liu, Katherine Cosmopoulos et al. · Cancer Research · 2012 · 101 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Refining the In Vitro and In Vivo Critical Parameters for P-Glycoprotein, [I]/IC₅₀and [I₂]/IC₅₀, That Allow for the Exclusion of Drug Candidates from Clinical Digoxin Interaction Studies

Jack Cook, Bo Feng, Katherine S. Fenner et al. · Molecular Pharmaceutics · 2009 · 58 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Direct Analysis in Real Time Coupled with Dried Spot Sampling for Bioanalysis in a Drug-Discovery Setting

Elizabeth A. Crawford, Justin Gordon, Jing‐Tao Wu et al. · Bioanalysis · 2011 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Nedd8-Activating Enzyme Inhibitor MLN4924 Provides Synergy with Mitomycin C through Interactions with ATR, BRCA1/BRCA2, and Chromatin Dynamics Pathways

Khristofer Garcia, Jonathan L. Blank, David C. Bouck et al. · Molecular Cancer Therapeutics · 2014 · 50 citations · Full text

Life Sciences, Molecular Biology, Oncology +16